New insider activity at Stryker ( (SYK) ) has taken place on February 6, 2026.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Director Ronda Stryker has executed a major sale of Stryker stock, offloading 500,000 shares in a single transaction. The deal, valued at $181,717,233, represents a substantial liquidation of her holdings and stands out as a significant insider transaction in the company’s recent trading activity.
Recent Updates on SYK stock
Over the last day, Stryker’s shares have traded around a strong Q4 earnings release and 2026 outlook, with options pricing having anticipated a larger-than-usual post-earnings move. The company beat revenue and EPS expectations, showcasing double‑digit organic growth, record momentum in its Mako robotics franchise, and standout performance in MedSurg & Neurotechnology, instruments, and endoscopy, while also expanding operating margins and generating robust free cash flow. Management’s 2026 guidance for high single‑digit organic sales growth and double‑digit EPS growth, helped by healthy procedure volumes, solid hospital capital demand, modestly positive pricing, and slightly favorable FX, underpinned a constructive fundamental story despite acknowledged headwinds from tariffs, higher interest expense, competitive pressure in parts of the vascular ischemic business, and softer European capital spending. Analyst price-target and rating actions referenced in the articles have mainly been driven by the view that Stryker’s strong growth, innovation leadership in robotics, and consistent beat/raise track record are already well understood and largely reflected in the current valuation, prompting more cautious stances not because of deteriorating fundamentals, but because upside is seen as more dependent on new, underappreciated growth drivers that could create unexpected positive surprises beyond what is already priced in.
Spark’s Take on SYK Stock
According to Spark, TipRanks’ AI Analyst, SYK is a Outperform.
The score is driven primarily by strong financial performance (consistent growth, solid margins, improving leverage, and strong cash flow) and a constructive earnings outlook (8.0%–9.5% organic growth guidance with continued robotics momentum). These positives are tempered by premium valuation (P/E ~42) and only moderately supportive technicals (below the 200-day average), alongside cited headwinds like tariffs and higher interest expense.
To see Spark’s full report on SYK stock, click here.
More about Stryker
YTD Price Performance: 3.12%
Average Trading Volume: 1,832,105
Technical Sentiment Signal: Hold
Current Market Cap: $137.9B